Document Detail


Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
MedLine Citation:
PMID:  383254     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two regimens of chemotherapy for metastatic breast cancer were compared in a randomized controlled fashion. Regimen 1 consisted of cyclophosphamide, vinblastine, methotrexate and 5-fluorouracil (CVMF). Regimen 2 consisted of cyclophosphamide, adriamycin, methotrexate and 5-fluorouracil (CAMF). The patient population consisted of both black and white postmenopausal females who had not received any prior chemotherapy. Objective responses were observed in 25/57 patients treated with CVMF and in 28/51 patients treated with CAMF. Neither race nor choice of chemotherapeutic regimen affected prognosis, although there were differences in the pattern of metastatic involvement between the two racial groups. The median duration of survival of patients who responded to therapy has not yet been reached but will be in excess of 12 months.
Authors:
W R Bezwoda; N G de Moor; D Derman; M Lange; R Saner; R Dando
Related Documents :
21640634 - Igf-1r expression predicts clinical outcome in patients with locally advanced oral squa...
22151964 - Efficacy of vinblastine in central nervous system langerhans cell histiocytosis: a nati...
24574464 - Comparison of survival rates between papillary and follicular thyroid carcinomas among ...
6307334 - A comparison between a single agent short course chemotherapy regimen and a quadruple p...
6498764 - Management of children with isolated testicular leukemia.
20131014 - Risk factors for lymph node metastasis from gastric cancers with submucosal invasion.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Cancer     Volume:  44     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1979 Aug 
Date Detail:
Created Date:  1979-11-21     Completed Date:  1979-11-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  392-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antineoplastic Agents / administration & dosage*,  adverse effects
Bone Marrow / drug effects
Breast Neoplasms / drug therapy*,  secondary
Clinical Trials as Topic
Doxorubicin / administration & dosage*
Drug Therapy, Combination
Female
Humans
Middle Aged
Remission, Spontaneous
Vinblastine / administration & dosage*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 23214-92-8/Doxorubicin; 865-21-4/Vinblastine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A critical analysis of the classifications of non-Hodgkin's lymphomas.
Next Document:  Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.